Stay updated with breaking news from Chris Parris. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
A new study published in Nature's cancer journal Oncogene highlights the effectiveness of MDX-124, the first therapeutic drug to target annexin-A1, a protein which is overexpressed in several cancer types and promotes tumour progression.
MDX-124, targeting annexin-A1, shows efficacy in cancer, per Oncogene study in Nature.
MDX-124, targeting annexin-A1, shows efficacy in cancer, per Oncogene study in Nature.
This season’s crop of promising debut fiction offers timeless human dramas from fresh perspectives.
A spate of mass shootings and violence across the U.S. over the weekend killed at least six people including a Pennsylvania state trooper.